Investigating the effectiveness of creative theater in reducing HIV-related social stigma among nursing students

Investigating the effectiveness of art therapy using creative theater in reducing HIV-related stigma in nursing students

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250516065759N1

Enrollment

Registered

2025-12-19

Start date

2026-01-21

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV. Human immunodeficiency virus [HIV] disease

Interventions

Intervention 1: Intervention group:The intervention group consists of nursing students at Tehran University of Medical Sciences who participate in six group sessions of creative theatre. The sessions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Nursing students who have acceptable knowledge about HIV. Nursing students who have entered clinical and hospital departments.

Exclusion criteria

Exclusion criteria: Nursing students who are in a period of neurological and psychiatric problems and disorders. Nursing students who are undergoing treatment with neurological and psychiatric drugs and even psychotherapy and psychoanalysis.

Design outcomes

Primary

Measure	Time frame
Social stigma associated with HIV. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;Internalized anxiety. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;Perceived discrimination. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;Perceived fear of HIV transmission. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;HIV-related social judgment. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.	—

Measure

Time frame

Social stigma associated with HIV. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;Internalized anxiety. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;Perceived discrimination. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;Perceived fear of HIV transmission. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.;HIV-related social judgment. Timepoint: The study outcomes will be measured at two time points: before the intervention (pre-test) and two weeks after the completion of the intervention (post-test). Method of measurement: HIV-related social stigma assessment questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLadan Abbasian

Tehran University of Medical Sciences

la.abbasian@gmail.com+98 21 6658 1583

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026